ANIP Similar Chart Price Prediction
The price of ANIP is predicted to go up 7.54%, based on the high correlation periods with NAII. The similarity of these two price pattern on the periods is 95.68%.
ANIP
NAII
Up: 7.54%Similarity: 95.68%
ANIP Revenue Forecast
ANIP EPS Forecast
ANIP FAQs
What is bull’s view on ANIP?
What is bear's view on ANIP?
What is ANIP revenue forecast for next quarter？
What is ANIP eps forecast for next quarter？
ANIP Analyst's Forecast
Faisal Khurshid
Leerink Partners
Buy
Price Target
$80
Upside
+35.51%
Leerink initiated coverage of ANI Pharmaceuticals with an Outperform rating and $80 price target. The firm believes the market is yet to fully appreciate the evolution of the story towards branded drugs with durable growth potential. The generics business provides a fundamental base, and Leerink sees decent growth potential in the rare disease products even as they occupy a minor position in their respective disease states. ANI Pharmaceuticals trades at a modest premium to specialty/generics peers, and the firm's thesis is that multiple expansion will occur as investors better appreciate the growth opportunity and the company executes on enhancing its rare disease portfolio.
David Amsellem
Piper Sandler
Buy
Price Target
$68
Upside
+19.01%
Elliot Wilbur
Raymond James
Buy
Price Target
$81 → $83
Upside
+35.95%